pre-seed
Stage
About
Calder Biosciences applies proprietary molecular engineering technology to develop subunit vaccines that stabilize viral proteins in their most immunogenic form, targeting RSV, influenza, Epstein-Barr virus, and other viral infections.
Explore Calder Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.